|
PFAS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.756600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.526400E-01 |
| Normal-vs-Stage2 |
2.051700E-02 |
| Normal-vs-Stage3 |
1.094220E-01 |
| Normal-vs-Stage4 |
1.899750E-01 |
| Stage1-vs-Stage2 |
7.597100E-03 |
| Stage1-vs-Stage3 |
3.938400E-02 |
| Stage1-vs-Stage4 |
1.025640E-01 |
| Stage2-vs-Stage3 |
4.802600E-01 |
| Stage2-vs-Stage4 |
5.088000E-01 |
| Stage3-vs-Stage4 |
9.668400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.027050E-01 |
| Normal-vs-AfricanAmerican |
2.753000E-01 |
| Normal-vs-Asian |
8.363300E-04 |
| Caucasian-vs-AfricanAmerican |
1.608260E-02 |
| Caucasian-vs-Asian |
2.820200E-03 |
| AfricanAmerican-vs-Asian |
9.385600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.393430E-01 |
| Normal-vs-Female |
8.906200E-01 |
| Male-vs-Female |
1.189770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.631400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.312800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.374020E-01 |
| Normal-vs-Age(81-100Yrs) |
2.665600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.073000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.674200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.406400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.641800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.454000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.339200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.097700E-02 |
| Normal-vs-Grade 2 |
3.855400E-01 |
| Normal-vs-Grade 3 |
5.083400E-01 |
| Normal-vs-Grade 4 |
1.025200E-01 |
| Grade 1-vs-Grade 2 |
5.558400E-02 |
| Grade 1-vs-Grade 3 |
3.250400E-02 |
| Grade 1-vs-Grade 4 |
7.756900E-03 |
| Grade 2-vs-Grade 3 |
9.074200E-01 |
| Grade 2-vs-Grade 4 |
2.443400E-01 |
| Grade 3-vs-Grade 4 |
2.427200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.627400E-01 |
| Normal-vs-ccB subtype |
5.058600E-01 |
| ccA subtype-vs-ccB subtype |
9.633000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.786200E-01 |
| Normal-vs-N1 |
2.808000E-01 |
| N0-vs-N1 |
4.890500E-02 |
|
|
